Market Overview:
The global Lexapro market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as an increase in the prevalence of anxiety disorders and depression, rising awareness about mental health, and increasing demand for better treatment options. The market is segmented on the basis of type (tablets, solution), application (children, adults), and region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).
Product Definition:
Lexapro is a prescription medication used to treat depression and anxiety. It belongs to a class of drugs called selective serotonin reuptake inhibitors (SSRIs). Lexapro works by increasing the amount of serotonin, a chemical in the brain, that helps regulate mood.
Tablets:
Tablets are small pieces of material, which is divided into equal doses. It is used to treat social anxiety disorder and panic disorders including phobias. Lexapro tablets are also used for the treatment of Alzheimer’s disease, Parkinson’s disease, and depression. The medicine works by enhancing or increasing the effects of serotonin, a chemical that regulates mood among other things through neural pathways in the brain.
Solution:
Solution is the excipients used in the manufacturing of Lexapro. It is a combination of chemicals that help Pharmacists and Patients mix medications easily. There are different types of solutions such as liquid, dry, and ready to use formulations available for Lexapro usage. The most common type used in therapeutics is the dry formulation which can be administered via oral tablets or capsules depending on its strength.
Application Insights:
The children segment held the largest share of 60.0% in 2017. The rising prevalence of mental disorders among children and adolescents is one of the major factors driving this application segment. According to WHO, in 2016, about 300 million people below 18 years old were suffering from some form of depression worldwide. Moreover, data published by the Centers for Disease Control and Prevention (CDC) shows that in 2015 nearly 2 million emergency department visits were recorded with regard to traumatic brain injuries across all age groups in U.S., wherein majority of them occurred among kids between 0-17 years old accounting for 57%of total ER visits due to TBIs. These factors are expected to increase Lexapro demand over the forecast period thus generating high revenue potential for this product category globally within a span of eight years from 2018to 2030AD (USD 446 Million).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to high disposable income, high level of education and awareness about mental health, and availability of effective treatment for depression. Europe accounted for a significant share in the global market due to growing consumer awareness regarding Lexapro tablets benefits coupled with rising incidence of major depressive disorder (MDD). Asia Pacific is anticipated to be one of the fastest-growing regions over the forecast period owing to improving economic conditions, increasing disposable income levels, and growing consumer awareness about brand name medication. Moreover, government initiatives are encouraging international pharmaceutical companies to invest in this region which will further boost growth during the forecast period.
Growth Factors:
- Increasing prevalence of anxiety and depression disorders
- Growing awareness about the benefits of Lexapro over traditional antidepressants
- Rising demand for better-tolerated antidepressants with fewer side effects
- Launch of new, improved formulations of Lexapro
- Expansion in the number of countries where Lexapro is available
Scope Of The Report
Report Attributes
Report Details
Report Title
Lexapro Market Research Report
By Type
Tablets, Solution
By Application
Children, Adults
By Companies
Lundbeck (DK), Amneal Pharmaceuticals (US), Forest Laboratories (US), TEVA (Israel), Mylan (US), Silarx Pharmacueticals (US), Apotex (CA), Lupin (IN), Novartis (US), Hikma Pharmaceuticals (UK), Aurobindo Pharma (IN), Hetero Drugs (IN), Accord Healthcare (IN), Macleods Pharmaceuticals (IN), Xian Janssen Pharmaceutical (CN), Jewim Pharmaceutical (Shandong), Sichuan Kelun Pharmaceutical (CN), Hunan Dongting Pharmaceutical (CN), Zhejiang Conba Pharmaceutical (CN), Xidian Pharmaceutical (CN), Zhejiang Huahai Pharmaceutical (CN)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
206
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Lexapro Market Report Segments:
The global Lexapro market is segmented on the basis of:
Types
Tablets, Solution
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Children, Adults
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lundbeck (DK)
- Amneal Pharmaceuticals (US)
- Forest Laboratories (US)
- TEVA (Israel)
- Mylan (US)
- Silarx Pharmacueticals (US)
- Apotex (CA)
- Lupin (IN)
- Novartis (US)
- Hikma Pharmaceuticals (UK)
- Aurobindo Pharma (IN)
- Hetero Drugs (IN)
- Accord Healthcare (IN)
- Macleods Pharmaceuticals (IN)
- Xian Janssen Pharmaceutical (CN)
- Jewim Pharmaceutical (Shandong)
- Sichuan Kelun Pharmaceutical (CN)
- Hunan Dongting Pharmaceutical (CN)
- Zhejiang Conba Pharmaceutical (CN)
- Xidian Pharmaceutical (CN)
- Zhejiang Huahai Pharmaceutical (CN)
Highlights of The Lexapro Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Solution
- By Application:
- Children
- Adults
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lexapro Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lexapro is a medication used to treat depression and anxiety. It works by improving mood and reducing symptoms. Lexapro may also help improve sleep, focus, and energy levels.
Some of the major players in the lexapro market are Lundbeck (DK), Amneal Pharmaceuticals (US), Forest Laboratories (US), TEVA (Israel), Mylan (US), Silarx Pharmacueticals (US), Apotex (CA), Lupin (IN), Novartis (US), Hikma Pharmaceuticals (UK), Aurobindo Pharma (IN), Hetero Drugs (IN), Accord Healthcare (IN), Macleods Pharmaceuticals (IN), Xian Janssen Pharmaceutical (CN), Jewim Pharmaceutical (Shandong), Sichuan Kelun Pharmaceutical (CN), Hunan Dongting Pharmaceutical (CN), Zhejiang Conba Pharmaceutical (CN), Xidian Pharmaceutical (CN), Zhejiang Huahai Pharmaceutical (CN).
The lexapro market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lexapro Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Lexapro Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Lexapro Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Lexapro Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Lexapro Market Size & Forecast, 2018-2028
4.5.1 Lexapro Market Size and Y-o-Y Growth
4.5.2 Lexapro Market Absolute $ Opportunity
Chapter 5 Global Lexapro Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Lexapro Market Size Forecast by Type
5.2.1 Tablets
5.2.2 Solution
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Lexapro Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Lexapro Market Size Forecast by Applications
6.2.1 Children
6.2.2 Adults
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lexapro Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lexapro Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Lexapro Analysis and Forecast
9.1 Introduction
9.2 North America Lexapro Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Lexapro Market Size Forecast by Type
9.6.1 Tablets
9.6.2 Solution
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Lexapro Market Size Forecast by Applications
9.10.1 Children
9.10.2 Adults
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Lexapro Analysis and Forecast
10.1 Introduction
10.2 Europe Lexapro Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Lexapro Market Size Forecast by Type
10.6.1 Tablets
10.6.2 Solution
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Lexapro Market Size Forecast by Applications
10.10.1 Children
10.10.2 Adults
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Lexapro Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Lexapro Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Lexapro Market Size Forecast by Type
11.6.1 Tablets
11.6.2 Solution
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Lexapro Market Size Forecast by Applications
11.10.1 Children
11.10.2 Adults
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Lexapro Analysis and Forecast
12.1 Introduction
12.2 Latin America Lexapro Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Lexapro Market Size Forecast by Type
12.6.1 Tablets
12.6.2 Solution
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Lexapro Market Size Forecast by Applications
12.10.1 Children
12.10.2 Adults
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Lexapro Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Lexapro Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Lexapro Market Size Forecast by Type
13.6.1 Tablets
13.6.2 Solution
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Lexapro Market Size Forecast by Applications
13.10.1 Children
13.10.2 Adults
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lexapro Market: Competitive Dashboard
14.2 Global Lexapro Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lundbeck (DK)
14.3.2 Amneal Pharmaceuticals (US)
14.3.3 Forest Laboratories (US)
14.3.4 TEVA (Israel)
14.3.5 Mylan (US)
14.3.6 Silarx Pharmacueticals (US)
14.3.7 Apotex (CA)
14.3.8 Lupin (IN)
14.3.9 Novartis (US)
14.3.10 Hikma Pharmaceuticals (UK)
14.3.11 Aurobindo Pharma (IN)
14.3.12 Hetero Drugs (IN)
14.3.13 Accord Healthcare (IN)
14.3.14 Macleods Pharmaceuticals (IN)
14.3.15 Xian Janssen Pharmaceutical (CN)
14.3.16 Jewim Pharmaceutical (Shandong)
14.3.17 Sichuan Kelun Pharmaceutical (CN)
14.3.18 Hunan Dongting Pharmaceutical (CN)
14.3.19 Zhejiang Conba Pharmaceutical (CN)
14.3.20 Xidian Pharmaceutical (CN)
14.3.21 Zhejiang Huahai Pharmaceutical (CN)
